Herceptin (trastuzumab): Herceptin (trastuzumab) is a targetted therapy that inhibits her2-neu receptor . Herceptin (trastuzumab) has been given to patient with her2neu receptor positive breast cancer with improvement of response and survival. Herceptin (trastuzumab) has been also one of treatment options for her2 reeptor positive stomach cancer. Read. Mire about Herceptin (trastuzumab) at www.Cancer.Net, www.Cancer.Org, www.Nccn.Com.
Answered 6/25/2014
5.5k views
4 doctors weighed in across 2 answers
4 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question